Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bolar and Vitarine sued again

Executive Summary

Generic firms sued in class action filed in Pennsylvania federal court by SmithKline Beecham shareholders, Bolar disclosed June 27. Complaint alleges violations of racketeering and federal securities statutes "in connection with allegations that Bolar and Vitarine submitted false or misleading information to FDA in gaining approval" of generic versions of Dyazide, Bolar notes. Smith-Kline Beecham also filed a complaint against the two firms and Schein alleging unfair competition ("The Pink Sheet" June 18, T&G-8).
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS017673

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel